Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Long-term follow-up data on sustained immunogenicity and safety for Gardasil 9 published in Pediatrics – Merck Inc

Written by | 12 Sep 2023

Merck Inc., known as MSD outside of the United States and Canada, announced new, 10-year long-term follow-up (LTFU) data published in the peer reviewed journal, Pediatrics, for girls… read more.

FDA approval of additional indication for Vyxeos for the treatment of secondary acute myeloid leukemia in pediatric patients – Jazz Pharma

Written by | 13 Apr 2021

Jazz Pharmaceuticals plc has announced that the FDA approved a revised label for Vyxeos (daunorubicin and cytarabine) to include a new indication to treat newly-diagnosed therapy-related acute myeloid… read more.

Soft “sweat stickers” may streamline diagnosis of cystic fibrosis in children

Written by | 11 Apr 2021

New “sweat stickers” may streamline the early diagnosis of cystic fibrosis by enabling scientists to easily gather and analyze sweat from the skin of infants and children. The… read more.

FDA approves Qelbree for attention-deficit hyperactivity disorder in pediatric patients – Supernus Pharmaceuticals

Written by | 10 Apr 2021

Supernus Pharmaceuticals announced that the FDA approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age…. read more.

Stem cell transplants prevent relapses of most common childhood cancer

Written by | 6 Apr 2021

Children and young adults who receive CAR T-cell therapy for the most common childhood cancer – acute lymphoblastic leukemia – suffer remarkably fewer relapses and are far more… read more.

Gut microbiota in cesarean-born babies catches up

Written by | 3 Apr 2021

Infants born by cesarean section have a relatively meager array of bacteria in the gut. But by the age of three to five years they are broadly in… read more.

Health Canada approves Taltz for pediatric patients with plaque psoriasis – Eli Lilly

Written by | 2 Apr 2021

Health Canada issued a Notice of Compliance for Taltz (ixekizumab), from Eli Lilly, injection, 80 mg/mL, for the treatment of pediatric patients from six to less than 18… read more.

FDA approves supplemental NDA for Exparel for postsurgical local analgesia in pediatric patients – Pacira BioSciences

Written by | 29 Mar 2021

Pacira BioSciences, Inc. announced the FDA has approved the submission of its supplemental new drug application (sNDA) seeking expansion of the Exparel label to include use in patients… read more.

Telehealth trains parents to improve autism

Written by | 15 Oct 2020

Training parents of children with autism spectrum disorder virtually about early behavioral intervention is an accessible and effective approach during the coronavirus pandemic or in other instances when… read more.

Scarlet fever’s re-emergence

Written by | 14 Oct 2020

A University of Queensland-led team of international researchers says supercharged “clones” of the bacteria Streptococcus pyogenes are to blame for the resurgence of the disease, which has caused high death… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.